GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:STSEY) » Definitions » EV-to-Revenue

Stratec SE (Stratec SE) EV-to-Revenue : 6.05 (As of May. 01, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Stratec SE EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Stratec SE's enterprise value is $1,710.2 Mil. Stratec SE's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $282.5 Mil. Therefore, Stratec SE's EV-to-Revenue for today is 6.05.

The historical rank and industry rank for Stratec SE's EV-to-Revenue or its related term are showing as below:

STSEY' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.7   Med: 3.67   Max: 6.95
Current: 2.4

During the past 13 years, the highest EV-to-Revenue of Stratec SE was 6.95. The lowest was 1.70. And the median was 3.67.

STSEY's EV-to-Revenue is ranked better than
57.84% of 823 companies
in the Medical Devices & Instruments industry
Industry Median: 3.16 vs STSEY: 2.40

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-01), Stratec SE's stock price is $26.25. Stratec SE's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $4.65. Therefore, Stratec SE's PS Ratio for today is 5.65.


Stratec SE EV-to-Revenue Historical Data

The historical data trend for Stratec SE's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE EV-to-Revenue Chart

Stratec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.75 6.22 5.94 3.82 2.52

Stratec SE Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.82 2.83 2.75 2.03 2.52

Competitive Comparison of Stratec SE's EV-to-Revenue

For the Medical Devices subindustry, Stratec SE's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stratec SE's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Stratec SE's EV-to-Revenue falls into.



Stratec SE EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Stratec SE's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1710.175/282.501
=6.05

Stratec SE's current Enterprise Value is $1,710.2 Mil.
Stratec SE's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $282.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stratec SE  (OTCPK:STSEY) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Stratec SE's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=26.25/4.646
=5.65

Stratec SE's share price for today is $26.25.
Stratec SE's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.65.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stratec SE EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Stratec SE's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Stratec SE (Stratec SE) Business Description

Traded in Other Exchanges
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus